v3.26.1
Consolidated Statements of Convertible Preferred Stock, Redeemable Noncontrolling Interest and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Common Class A and B
Additional Paid-in Capital
Accumulated Deficit
Accumulated other Comprehensive Income (Loss)
Beginning balance at Jan. 31, 2023 $ 1,455        
Noncontrolling Interest [Roll Forward]          
Net income (loss) attributable to redeemable non-controlling interest (1,263)        
Ending balance at Jan. 31, 2024 192        
Beginning balance (in shares) at Jan. 31, 2023   95,975,000      
Beginning balance at Jan. 31, 2023 445,303 $ 10 $ 806,044 $ (353,927) $ (6,824)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for options exercised (in shares)   1,955,000      
Issuance of common stock for options exercised 7,263   7,263    
Issuance of common stock under employee stock purchase plan   234,000      
Issuance of common stock under employee stock purchase plan 6,011   6,011    
Vesting of restricted stock units (in shares)   1,760,000      
Stock-based compensation 99,293   99,293    
Other comprehensive income 5,646       5,646
Charitable donation of stock (in shares)   96,000      
Charitable donation of stock 3,762   3,762    
Issuance of common stock from acquisition (in shares)   190,000      
Issuance of common stock from acquisition 6,121   6,121    
Net loss attributable to Braze, Inc. (129,166)     (129,166)  
Ending balance (in shares) at Jan. 31, 2024   100,210,000      
Ending balance at Jan. 31, 2024 444,233 $ 10 928,494 (483,093) (1,178)
Noncontrolling Interest [Roll Forward]          
Net income (loss) attributable to redeemable non-controlling interest (304)        
Ending balance at Jan. 31, 2025 $ (112)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for options exercised (in shares) 990,063 990,000      
Issuance of common stock for options exercised $ 6,906   6,906    
Issuance of common stock under employee stock purchase plan   234,000      
Issuance of common stock under employee stock purchase plan 7,705   7,705    
Vesting of restricted stock units (in shares)   2,421,000      
Stock-based compensation 115,732   115,732    
Other comprehensive income 252       252
Charitable donation of stock (in shares)   96,000      
Charitable donation of stock 3,776   3,776    
Net loss attributable to Braze, Inc. (103,743)     (103,743)  
Ending balance (in shares) at Jan. 31, 2025   103,951,000      
Ending balance at Jan. 31, 2025 474,861 $ 10 1,062,613 (586,836) (926)
Noncontrolling Interest [Roll Forward]          
Net income (loss) attributable to redeemable non-controlling interest 501        
Ending balance at Jan. 31, 2026 $ 389        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for options exercised (in shares) 1,732,084 1,733,000      
Issuance of common stock for options exercised $ 15,861   15,861    
Issuance of common stock under employee stock purchase plan   276,000      
Issuance of common stock under employee stock purchase plan 7,099   7,099    
Vesting of restricted stock units (in shares)   2,807,000      
Stock-based compensation 143,667   143,667    
Other comprehensive income 2,714       2,714
Charitable donation of stock (in shares)   96,000      
Charitable donation of stock 3,223   3,223    
Issuance of common stock from acquisition (in shares)   2,019,000      
Issuance of common stock from acquisition 73,752 $ 1 73,751    
Replacement share-based awards issued in connection with acquisition 33,877   33,877    
Net loss attributable to Braze, Inc. (131,287)     (131,287)  
Ending balance (in shares) at Jan. 31, 2026   110,882,000      
Ending balance at Jan. 31, 2026 $ 623,767 $ 11 $ 1,340,091 $ (718,123) $ 1,788